Annual Net Margin
-401.57%
-223.56%-125.59%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual net profit margin is -401.57%, with the most recent change of -223.56% (-125.59%) on December 31, 2023.
- During the last 3 years, ABUS annual net margin has risen by +520.40% (+56.44%).
- ABUS annual net margin is now -2375.77% below its all-time high of -16.22%, reached on December 31, 2007.
Performance
ABUS Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-1472.52%
-325.59%-28.39%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly net profit margin is -1472.52%, with the most recent change of -325.59% (-28.39%) on September 30, 2024.
- Over the past year, ABUS quarterly net margin has dropped by -305.74% (-26.20%).
- ABUS quarterly net margin is now -5690.43% below its all-time high of 26.34%, reached on September 30, 2007.
Performance
ABUS Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
ABUS Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -125.6% | -26.2% |
| 3 y3 years | +56.4% | -319.3% |
| 5 y5 years | +58.2% | -319.3% |
ABUS Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -125.6% | +42.1% | -1377.5% | at low |
| 5 y | 5-year | -125.6% | +84.3% | -1377.5% | +3.4% |
| alltime | all time | -2375.8% | +98.4% | -5690.4% | +96.5% |
Arbutus Biopharma Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -1472.52%(+28.4%) |
| Jun 2024 | - | -1146.93%(-1.7%) |
| Mar 2024 | - | -1166.78%(+29.6%) |
| Dec 2023 | -401.57%(+125.6%) | -900.33%(+108.6%) |
| Sep 2023 | - | -431.60%(+17.4%) |
| Jun 2023 | - | -367.53%(+50.4%) |
| Mar 2023 | - | -244.34%(-30.4%) |
| Dec 2022 | -178.01%(-74.3%) | -351.19%(+19.0%) |
| Sep 2022 | - | -295.14%(+196.1%) |
| Jun 2022 | - | -99.66%(-20.5%) |
| Mar 2022 | - | -125.31%(-81.2%) |
| Dec 2021 | -693.91%(-24.7%) | -665.03%(+15.9%) |
| Sep 2021 | - | -573.59%(-31.1%) |
| Jun 2021 | - | -832.42%(+7.4%) |
| Mar 2021 | - | -775.25%(+8.5%) |
| Dec 2020 | -921.97%(-63.9%) | -714.25%(-42.0%) |
| Sep 2020 | - | -1231.45%(+32.3%) |
| Jun 2020 | - | -930.45%(+0.1%) |
| Mar 2020 | - | -929.64%(-39.0%) |
| Dec 2019 | -2557.36%(+166.4%) | -1523.73%(-43.5%) |
| Sep 2019 | - | -2695.30%(-24.5%) |
| Jun 2019 | - | -3570.44%(+4.3%) |
| Mar 2019 | - | -3424.30%(+214.9%) |
| Dec 2018 | -959.80%(+21.7%) | -1087.54%(-29.5%) |
| Sep 2018 | - | -1542.09%(+27.1%) |
| Mar 2018 | - | -1213.72%(-14.4%) |
| Dec 2017 | -788.91%(-96.9%) | -1417.96%(+742.5%) |
| Sep 2017 | - | -168.31%(-90.4%) |
| Jun 2017 | - | -1756.98%(-77.8%) |
| Mar 2017 | - | -7926.38%(+213.1%) |
| Dec 2016 | -25.77 K%(+9462.3%) | - |
| Sep 2016 | - | -2531.65%(-94.0%) |
| Jun 2016 | - | -42.07 K%(+1498.1%) |
| Mar 2016 | - | -2632.50%(+4154.9%) |
| Dec 2015 | -269.45%(+3.7%) | -61.87%(-91.3%) |
| Sep 2015 | - | -712.96%(+64.8%) |
| Jun 2015 | - | -432.73%(+69.0%) |
| Mar 2015 | - | -256.07%(+80.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -259.73%(+185.6%) | -141.79%(-28.1%) |
| Sep 2014 | - | -197.25%(-41.3%) |
| Jun 2014 | - | -335.78%(-17.3%) |
| Mar 2014 | - | -405.96%(+1076.0%) |
| Dec 2013 | -90.93%(+51.6%) | -34.52%(-82.7%) |
| Sep 2013 | - | -199.29%(+88.0%) |
| Jun 2013 | - | -105.98%(-11.3%) |
| Mar 2013 | - | -119.42%(+6.0%) |
| Sep 2012 | - | -112.71%(+112.1%) |
| Jun 2012 | - | -53.13%(-40.1%) |
| Mar 2012 | - | -88.66%(+70.0%) |
| Dec 2011 | -59.98%(+3.2%) | -52.16%(+47.7%) |
| Sep 2011 | - | -35.32%(-55.9%) |
| Jun 2011 | - | -80.13%(+12.4%) |
| Mar 2011 | - | -71.32%(+116.9%) |
| Dec 2010 | -58.14%(-4.1%) | -32.88%(+40.5%) |
| Sep 2010 | - | -23.40%(-86.3%) |
| Jun 2010 | - | -170.86%(+1.2%) |
| Mar 2010 | - | -168.84%(+356.2%) |
| Dec 2009 | -60.64%(-50.1%) | -37.01%(-57.2%) |
| Sep 2009 | - | -86.39%(+45.0%) |
| Jun 2009 | - | -59.58%(-17.3%) |
| Mar 2009 | - | -72.05%(+1.4%) |
| Dec 2008 | -121.56%(+649.4%) | -71.03%(-50.3%) |
| Sep 2008 | - | -142.83%(-25.6%) |
| Jun 2008 | - | -191.98%(+744.2%) |
| Mar 2008 | - | -22.74%(-371.7%) |
| Dec 2007 | -16.22%(-73.3%) | 8.37%(-68.2%) |
| Sep 2007 | - | 26.34%(-115.3%) |
| Jun 2007 | - | -172.45% |
| Dec 2005 | -60.64%(-73.7%) | - |
| Dec 2004 | -230.49%(-79.4%) | - |
| Dec 2003 | -1120.43%(+84.4%) | - |
| Dec 2002 | -607.50%(+35.0%) | - |
| Dec 2001 | -450.05%(-97.6%) | - |
| Dec 2000 | -19.05 K%(+2558.4%) | - |
| Dec 1999 | -716.68%(+0.5%) | - |
| Dec 1998 | -713.22% | - |
FAQ
- What is Arbutus Biopharma annual net profit margin?
- What is the all time high annual net margin for Arbutus Biopharma?
- What is Arbutus Biopharma annual net margin year-on-year change?
- What is Arbutus Biopharma quarterly net profit margin?
- What is the all time high quarterly net margin for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly net margin year-on-year change?
What is Arbutus Biopharma annual net profit margin?
The current annual net margin of ABUS is -401.57%
What is the all time high annual net margin for Arbutus Biopharma?
Arbutus Biopharma all-time high annual net profit margin is -16.22%
What is Arbutus Biopharma annual net margin year-on-year change?
Over the past year, ABUS annual net profit margin has changed by -223.56% (-125.59%)
What is Arbutus Biopharma quarterly net profit margin?
The current quarterly net margin of ABUS is -1472.52%
What is the all time high quarterly net margin for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly net profit margin is 26.34%
What is Arbutus Biopharma quarterly net margin year-on-year change?
Over the past year, ABUS quarterly net profit margin has changed by -305.74% (-26.20%)